XREF LIMITED — Interim / Quarterly Report 2016

Jan 30, 2017

==> picture [162 x 56] intentionally omitted <==

Appendix 4C

Quarterly report for entities subject to Listing Rule 4.7B

Name of entity

Name of entity	Name of entity
Xref Limited
ARBN 122 404 666	Quarter ended("currentquarter")
122 404 666	31 December 2016

Consolidated statement of cash flows

1 Cash flows from operating activities 1.1 Receipts from customers 1.2 Payments for (a) research and development (b) product manufacturing and operating costs (c) advertising and marketing (d) leased assets (e) staff costs (f) administration and corporate costs 1.3 Dividends received 1.4 Interest received 1.5 Interest and other costs of finance paid 1.6 Income taxes paid 1.7 Government grants and tax incentives 1.8 Other (provide details if material) - Net GST received / (paid) 1.9 Net cash from /(used in) operating activities	Current quarter $A'000 666 (33) (72) (350) (171) (1,239) (707) - 15 - - 482 26	Year to date (6 months) $A'000 1,286 (74) (112) (496) (349) (2,160) (1,402) - 23 - 2 482 (61)
	(1,383)	(2,861)

	2 Cash flows from investing activities 2.1 Payments to acquire (a) property, plant and equipment (b) businesses (item 10) (c) investments (d) intellectual property (e) other non-current assets 2.2 Proceeds from disposal of: (a) property, plant and equipment (b) businesses (item 10) (c) investments (d) intellectual property (e) other non-current assets 2.3 Cash flows from loans to other entities 2.4 Dividends received (see note 3) 2.5 Other (provide details if material) - 2.6 Net cash from /(used in) investing activities	Current quarter $A'000 (30) - - - - - - - - - 13 - -	Year to date (6 months) $A'000 (72) - - - - - - - - - 23 - -
		(17)	(49)
	3 Cash flows related to financing activities 3.1 Proceeds from issues of shares 3.2 Proceeds from issue of convertible notes 3.3 Proceeds from exercise of share options 3.4 3.5 Proceeds from borrowings 3.6 Repayment of borrowings 3.7 3.8 Dividends paid 3.9 Other (provide details if material) 3.10 Net cash from /(used in) financing activities Transaction costs related to issues of shares, convertible notes or options Transaction costs related to loans and borrowings 3.4	- - - - - - - -	8,000 - - (540) - - - -
	3.4
		-	7,460

4 Net increase (decrease) in cash and cash equivalents for theperiod held	4 Net increase (decrease) in cash and cash equivalents for theperiod held	4 Net increase (decrease) in cash and cash equivalents for theperiod held
4.1 4.2 4.3 4.4 4.5 Effect of movement in exchange rates on cash held 4.6 Cash and cash equivalents at end ofquarter Cash and cash equivalents at beginning of quarter /year to date at beginning of quarter/year Net cash from / (used in) operating activities (item 1.9 above) Net cash from / (used in) investing activities (item 2.6 above) Net cash from / (used in) financing activities (item 3.10 above)	8,381 (1,383) (17) - 13	2,445 (2,861) (49) 7,460 (1)
	6,994	6,994
5 Reconciliation of cash and cash equivalents 5.1 Bank balances 5.2 Call deposits 5.3 Bank overdrafts 5.4 Other (provide details) 5.5 at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts Cash and cash equivalents at end of quarter (should equal item 4.6 above)	Current quarter $A'000 6,923 71 - -	Previous quarter $A'000 8,310 71 - -
	6,994	8,381
6 6.1 6.2 6.3 Aggregate amount of payments to these parties included in item 1.2 Aggregate amount of cash flow from loans to these parties included in item 2.3 Include below any explanation necessary to understand the transactions included in items 6.1 and 6.2 Payments to directors of the entity and associates of the directors	Current quarter $A'000 176 20
	Current quarter $A'000 176 20

7 7.1 7.2 7.3 Aggregate amount of payments to these parties included in item 1.2 Include below any explanation necessary to understand the transactions included in 7.1 and 7.2 Payments to related entities of the entity and associates of the related entities Aggregate amount of cash flow from loans to these parties included in item 2.3	Current quarter $A'000 91 -
	-

8 Financing facilities available

Total facility amount at quarter end Amount drawn at quarter end $A'000 $A'000 8.1 Loan facilities - - 8.2 Credit standby arrangements - - 8.3 Other (please specify) - - 8.4 Add notes as necessary for an understanding of the position. Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into afterquarter end,include details of those facilities as well.	Total facility amount at quarter end $A'000 - - -	Amount drawn at quarter end $A'000 - - -

9	Estimated cash outflows for next quarter	$A'000
9.1	Research and Development	50
9.2	Product manufacturing and operating costs	200
9.3	Advertising and marketing	350
9.4	Leased assets	180
9.5	Staff costs	1,625
9.6	Administration and corporate costs	350
9.7	Other (provide details if material)
9.8	Total estimated cash outflows	2,755

Acquisitions and disposals of business

• 10 entities (items 2.1(b) and 2.2 (b) above

• 10.1 Name of entity

• 10.2 Place of incorporation or registration

• 10.3 Consideration for acquisition or disposal

• 10.4 Total net assets

• 10.5 Nature of business

Acquisitions	Disposals
n/a	n/a

Compliance statement

• 1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.

• 2 This statement gives a true and fair view of the matters disclosed.

Sign here: ~~(Director/~~ Company Secretary)

Print name: Robert J WaringJames Solomons, CFO

Date: 31 January 201725th January 2017